Zigan Sha

Zigan Sha

Auto-generated profile, based on publicly available information

Zigan Sha

Shanghai Jiao Tong University No. 800 Dongchuan Road , Minhang

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2026 in JACS Au
Verified
Journal Article
Open access
ZHZheyao Hu
Zheyao Hu
ZSZigan Sha
Zigan Sha
Jordi MartiJordi Marti
Jordi Marti
SGShu-Juan Guo
Shu-Juan Guo
Shengce TaoShengce Tao
Shengce Tao
KRAS is among the most frequently mutated oncogenes in human cancers, with codon 12 representing a dominant hotspot. Despite decades of study, the atomic-level conformational dynamics of KRAS and its G12 mutations remain insufficiently resolved, posing a central barrier to rational drug discovery. Elucidating these dynamics is critical for revealing hidden druggable pockets and enabling the development of mutation-specific inhibitors. Here, we delineate the impact of KRAS G12 mutations on conformational dynamics and GTP binding by performing microsecond-scale, well-tempered metadynamics simulations. This approach yielded precise free energy landscapes that expose mutation-specific alterations to structural states. By introducing biologically meaningful collective variables, including key angles (ϕ) and distances (d1, d2) defining Switch-I, Switch-II, and the P-loop, we identified distinct local and global minima as well as their transition states. Analysis of these transitions reveals how G12 mutations reshape GTP affinity and drive aberrant KRAS activation. We further demonstrated the convergence of the simulations and discussed the physiological relevance of the calculation results in comparison to previously published experimental and theoretical data. Importantly, our analyses uncovered druggable pockets unique to nonpolar G12 mutants, offering novel entry points for inhibitor design. Collectively, this work provides an atomic-level framework for understanding KRAS G12 mutations, establishes transferable collective variables for broader RAS family studies, and opens new avenues for mutation-specific therapeutic development.

27 August 2026 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
ZSZigan Sha
Zigan Sha
ZHZheyao Hu
Zheyao Hu
WDWenjing Du
Wenjing Du
Jordi MartiJordi Marti
Jordi Marti
GSGustav N. Sundell
Gustav N. Sundell
Shengce TaoShengce Tao
Shengce Tao